P04.1
Fetus and newborn affected by other maternal medication
Coding guidance (WHO 2019)
Cancer chemotherapy Cytotoxic drugs Excl.:dysmorphism due to warfarin (Q86.2) fetal hydantoin syndrome (Q86.1) maternal use of drugs of addiction (P04.4)
Sibling codes
P04Fetus and newborn affected by noxious influences transmitted via placenta or breast milkP04.0Fetus and newborn affected by maternal anaesthesia and analgesia in pregnancy, labour and deliveryP04.2Fetus and newborn affected by maternal use of tobaccoP04.3Fetus and newborn affected by maternal use of alcoholP04.4Fetus and newborn affected by maternal use of drugs of addictionP04.5Fetus and newborn affected by maternal use of nutritional chemical substancesP04.6Fetus and newborn affected by maternal exposure to environmental chemical substancesP04.8Fetus and newborn affected by other maternal noxious influencesP04.9Fetus and newborn affected by maternal noxious influence, unspecified